PDF(Pubmed)
Abstract：
UNASSIGNED: Determine the economic cost or benefit of expanding electronic case reporting (eCR) for 29 reportable conditions beyond the initial eCR implementation for COVID-19 at an academic health center.
UNASSIGNED: The return on investment (ROI) framework was used to quantify the economic impact of the expansion of eCR from the perspective of an academic health system over a 5-year time horizon. Sensitivity analyses were performed to assess key factors such as personnel cost, inflation, and number of expanded conditions.
UNASSIGNED: The total implementation costs for the implementation year were estimated to be $5031.46. The 5-year ROI for the expansion of eCR for the 29 conditions is expected to be 142% (net present value of savings: $7166). Based on the annual ROI, estimates suggest that the savings from the expansion of eCR will cover implementation costs in approximately 4.8 years. All sensitivity analyses yielded a strong ROI for the expansion of eCR.
UNASSIGNED: Our findings suggest a strong ROI for the expansion of eCR at UHealth, with the most significant cost savings observed implementing eCR for all reportable conditions. An early effort to ensure data quality is recommended to expedite the transition from parallel reporting to production to improve the ROI for healthcare organizations. This study demonstrates a positive ROI for the expansion of eCR to additional reportable conditions beyond COVID-19 in an academic health setting, such as UHealth. While this evaluation focuses on the 5-year time horizon, the potential benefit could extend further.
UNASSIGNED: The return on investment (ROI) framework was used to quantify the economic impact of the expansion of eCR from the perspective of an academic health system over a 5-year time horizon. Sensitivity analyses were performed to assess key factors such as personnel cost, inflation, and number of expanded conditions.
UNASSIGNED: The total implementation costs for the implementation year were estimated to be $5031.46. The 5-year ROI for the expansion of eCR for the 29 conditions is expected to be 142% (net present value of savings: $7166). Based on the annual ROI, estimates suggest that the savings from the expansion of eCR will cover implementation costs in approximately 4.8 years. All sensitivity analyses yielded a strong ROI for the expansion of eCR.
UNASSIGNED: Our findings suggest a strong ROI for the expansion of eCR at UHealth, with the most significant cost savings observed implementing eCR for all reportable conditions. An early effort to ensure data quality is recommended to expedite the transition from parallel reporting to production to improve the ROI for healthcare organizations. This study demonstrates a positive ROI for the expansion of eCR to additional reportable conditions beyond COVID-19 in an academic health setting, such as UHealth. While this evaluation focuses on the 5-year time horizon, the potential benefit could extend further.
摘要：
■确定在学术卫生中心对COVID-19的初始eCR实施之外，对29种可报告病症扩大电子病例报告(eCR)的经济成本或收益。
■投资回报率（ROI）框架用于从5年时间范围内的学术卫生系统的角度量化eCR扩张的经济影响。进行了敏感性分析，以评估关键因素，如人员成本，通货膨胀,和扩展条件的数量。
■实施年度的总实施成本估计为5031.46美元。在29种情况下扩展eCR的5年ROI预计为142％（节省的净现值：7166美元）。根据年度投资回报率，估计表明，扩大eCR所节省的资金将在大约4.8年内支付实施成本。所有敏感性分析都为eCR的扩展产生了很强的ROI。
■我们的研究结果表明，UHealth的eCR扩展具有很高的ROI，观察到最显著的成本节约，在所有可报告的条件下实施eCR。建议尽早确保数据质量，以加快从并行报告到生产的过渡，以提高医疗保健组织的ROI。这项研究表明，在学术健康环境中，将eCR扩展到除COVID-19之外的其他可报告病症，具有积极的ROI，例如UHealth。虽然这项评估侧重于5年的时间范围，潜在的好处可能会进一步扩大。
■投资回报率（ROI）框架用于从5年时间范围内的学术卫生系统的角度量化eCR扩张的经济影响。进行了敏感性分析，以评估关键因素，如人员成本，通货膨胀,和扩展条件的数量。
■实施年度的总实施成本估计为5031.46美元。在29种情况下扩展eCR的5年ROI预计为142％（节省的净现值：7166美元）。根据年度投资回报率，估计表明，扩大eCR所节省的资金将在大约4.8年内支付实施成本。所有敏感性分析都为eCR的扩展产生了很强的ROI。
■我们的研究结果表明，UHealth的eCR扩展具有很高的ROI，观察到最显著的成本节约，在所有可报告的条件下实施eCR。建议尽早确保数据质量，以加快从并行报告到生产的过渡，以提高医疗保健组织的ROI。这项研究表明，在学术健康环境中，将eCR扩展到除COVID-19之外的其他可报告病症，具有积极的ROI，例如UHealth。虽然这项评估侧重于5年的时间范围，潜在的好处可能会进一步扩大。
